Drugmaker, GlaxoSmithKline, escapes criminal prosecution in Britian, for withholding information about adverse effects of its drug, Seroxat. Seroxat, is marketed in the United States, as Paxil. According to Britian authorities, GlaxoSmithKline had information that Seroxat could increase sucidial thoughts in teens under the age of 18. However, GlaxoSmithKline did not release that information to the Healthcare Regulatory Agency until four years later. GlaxoSmithKline did not believe it had an obligation to notifiy the Agency of the problems since the drug was not approved for use by teens. Since that time, the laws have been changed to make it clear when drugmakers must report adverse events in any study conducted in the country. The Agency now seeks to change the law so that regardless of where a study takes the place, the drug maker must report its results.
Comments are closed.